LBA
Letko, Brosseau & Associates Portfolio holdings
AUM
$5.23B
This Quarter Return
+9.05%
1 Year Return
+15.79%
3 Year Return
+49.62%
5 Year Return
+161.51%
10 Year Return
+219.13%
AUM
$6.98B
AUM Growth
+$6.98B
(+1.1%)
Cap. Flow
-$512M
Cap. Flow
% of AUM
-7.33%
Top 10 Holdings %
Top 10 Hldgs %
34.94%
Holding
110
New
5
Increased
17
Reduced
65
Closed
3
Top Buys
| 1 |
Restaurant Brands International
QSR
|
$33.4M |
| 2 |
VMW
VMware, Inc
VMW
|
$33M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$24.7M |
| 4 |
Rogers Communications
RCI
|
$23.4M |
| 5 |
Sabesp
SBS
|
$14.2M |
Top Sells
| 1 |
Cenovus Energy
CVE
|
$139M |
| 2 |
Canadian Natural Resources
CNQ
|
$125M |
| 3 |
Ovintiv
OVV
|
$85.2M |
| 4 |
Suncor Energy
SU
|
$41.3M |
| 5 |
Intel
INTC
|
$36.4M |
Sector Composition
| 1 | Financials | 29.03% |
| 2 | Communication Services | 16.04% |
| 3 | Materials | 14.13% |
| 4 | Energy | 13.16% |
| 5 | Healthcare | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Cenovus Energy Inc. Warrants (each warrant entitles the holder to purchase one common share at an exercise price of C$6.54 per share)
CVE.WS
$40.5M
| $12.6M | 0.18% |
1,698,512
-27,217
| -2% | -$203K |
|
77
Credicorp
BAP
$20.8B
| $10M | 0.14% |
82,025
-30,000
| -27% | -$3.66M |
|
|
PROF
78
Profound Medical
PROF
$131M
| $9.28M | 0.13% |
822,250
+4,275
| +0.5% | +$48.2K |
|
79
Goodyear
GT
$2.4B
| $8.69M | 0.12% |
407,558
-9,050
| -2% | -$193K |
|
80
Fortis
FTS
$24.9B
| $8.35M | 0.12% |
172,775
+2,000
| +1% | +$96.6K |
|
81
Fluor
FLR
$6.93B
| $7.45M | 0.11% |
300,820
-38,374
| -11% | -$950K |
|
|
PDS
82
Precision Drilling
PDS
$762M
| $5.04M | 0.07% |
142,421
-6,184
| -4% | -$219K |
|
83
Yatra Online
YTRA
$87.5M
| $3.7M | 0.05% |
2,138,020
| – | – |
|
84
Charles Schwab
SCHW
$175B
| $1.84M | 0.03% |
21,846
| – | – |
|
85
Vanguard Total World Stock ETF
VT
$51.4B
| $1.56M | 0.02% |
14,500
| – | – |
|
86
ING
ING
$71B
| $1.37M | 0.02% |
98,564
-1,136
| -1% | -$15.8K |
|
87
Spero Therapeutics
SPRO
$117M
| $1.18M | 0.02% |
73,659
| – | – |
|
88
Outset Medical
OM
$245M
| $1.04M | 0.01% |
22,500
| – | – |
|
89
Kyndryl
KD
$7.4B
| $992K | 0.01% |
+54,829
| New | +$992K |
|
|
MYOV
90
DELISTED
Myovant Sciences Ltd.
MYOV
| $984K | 0.01% |
63,204
| – | – |
|
91
MetLife
MET
$53.6B
| $819K | 0.01% |
13,099
| – | – |
|
92
Replimune Group
REPL
$460M
| $618K | 0.01% |
22,800
| – | – |
|
93
Heron Therapeutics
HRTX
$204M
| $522K | 0.01% |
57,200
| – | – |
|
94
Enbridge
ENB
$105B
| $417K | 0.01% |
10,650
+2,000
| +23% | +$78.3K |
|
95
Alibaba
BABA
$325B
| $368K | 0.01% |
3,100
+1,000
| +48% | +$119K |
|
96
Apple
AAPL
$3.54T
| $355K | 0.01% |
2,000
| – | – |
|
97
Nucor
NUE
$33.3B
| $331K | ﹤0.01% |
2,900
| – | – |
|
98
Duke Energy
DUK
$94.5B
| $325K | ﹤0.01% |
3,100
| – | – |
|
99
Kimberly-Clark
KMB
$42.5B
| $289K | ﹤0.01% |
2,025
| – | – |
|
|
RDS.B
100
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $256K | ﹤0.01% |
5,912
| – | – |
|